Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 4467

Sort by

Sort Order Select

Journal Articles

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing

Elisabeth Ehrend, Patricia Manns, Sabine Harenkamp, Erhard Seifried, Christof Geisen, Halvard Bonig

Blood (2021) 138 (9): 814–817.

https://doi.org/10.1182/blood.2021011396

Published: 2021

Includes: Supplemental data

Journal Articles

Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage

Jessica Magid-Bernstein, Charles B. Beaman, Fernanda Carvalho-Poyraz, Amelia Boehme, Eldad A. Hod, Richard O. Francis, Mitchell S. V. Elkind, Sachin Agarwal, Soojin Park, Jan Claassen, E. Sander Connolly, David Roh

Blood (2021) 137 (19): 2699–2703.

https://doi.org/10.1182/blood.2020008381

Published: 2021

Includes: Supplemental data

Journal Articles

Rapid clearance of storage-induced microerythrocytes alters transfusion recovery

Blood (2021) 137 (17): 2285–2298.

https://doi.org/10.1182/blood.2020008563

Published: 2021

Includes: Supplemental data

Journal Articles

How should we use convalescent plasma therapies for the management of COVID-19?

Erica M. Wood, Lise J. Estcourt, Zoe K. McQuilten

Blood (2021) 137 (12): 1573–1581.

https://doi.org/10.1182/blood.2020008903

Published: 2021

Journal Articles

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease

L. Joseph, C. Jean, S. Manceau, C. Chalas, C. Arnaud, A. Kamdem, C. Pondarré, A. Habibi, F. Bernaudin, S. Allali, M. de Montalembert, B. Boutonnat-Faucher, J.-B. Arlet, B. Koehl, M. Cavazzana, J.-A. Ribeil, F. Lionnet, I. Berthaut, V. Brousse

Blood (2021) 137 (6): 826–829.

https://doi.org/10.1182/blood.2020006270

Published: 2021

Journal Articles

Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat

Mark J. McVey, Sarah Weidenfeld, Mazharul Maishan, Chris Spring, Michael Kim, Arata Tabuchi, Victoria Srbely, Alisa Takabe-French, Szandor Simmons, Christoph Arenz, John W. Semple, Wolfgang M. Kuebler

Blood (2021) 137 (5): 690–701.

https://doi.org/10.1182/blood.2020005985

Published: 2021

Includes: Supplemental data

Journal Articles

HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern

Blood (2020) 136 (11): 1351–1358.

https://doi.org/10.1182/blood.2020006890

Published: 2020

Includes: Supplemental data

Journal Articles

HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men

Eduard Grebe, Michael P. Busch, Edward P. Notari, Roberta Bruhn, Claire Quiner, Daniel Hindes, Mars Stone, Sonia Bakkour, Hong Yang, Phillip Williamson, Debra Kessler, Rita Reik, Susan L. Stramer, Simone A. Glynn, Steven A. Anderson, Alan E. Williams, Brian Custer

Blood (2020) 136 (11): 1359–1367.

https://doi.org/10.1182/blood.2020007003

Published: 2020

Includes: Supplemental data

Journal Articles

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic

Robert Sheppard Nickel, Stefanie Margulies, Brittany Frazer, Naomi L. C. Luban, Jennifer Webb

Blood (2020) 135 (25): 2320–2322.

https://doi.org/10.1182/blood.2020006582

Published: 2020

Journal Articles

Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice

Vicente Escamilla-Rivera, Jingchun Liu, David R. Gibb, Manjula Santhanakrishnan, Dong Liu, James E. Forsmo, Stephanie C. Eisenbarth, Ellen F. Foxman, Sean R. Stowell, Chance John Luckey, James C. Zimring, Krystalyn E. Hudson, Jeanne E. Hendrickson

Blood (2020) 135 (22): 1983–1993.

https://doi.org/10.1182/blood.2020005018

Published: 2020

Includes: Supplemental data

Journal Articles

PATCH trial: explanatory analyses

M. Irem Baharoglu, Rustam Al-Shahi Salman, Charlotte Cordonnier, Maria M. Koopman, Lynn Manson, Sophie Susen, Henk A. Marquering, Ludo F. Beenen, Charles B. Majoie, Yvo B. Roos

Blood (2020) 135 (16): 1406–1409.

https://doi.org/10.1182/blood.2019003298

Published: 2020

Includes: Supplemental data

Journal Articles

PATCHing platelet data to improve transfusion

Eric A. Gehrie, Aaron A. R. Tobian

Blood (2020) 135 (16): 1309–1310.

https://doi.org/10.1182/blood.2020005384

Published: 2020

Journal Articles

Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways

Denis F. Noubouossie, Michael W. Henderson, Micah Mooberry, Anton Ilich, Patrick Ellsworth, Mark Piegore, Sarah C. Skinner, Rafal Pawlinski, Ian Welsby, Thomas Renné, Maureane Hoffman, Dougald M. Monroe, Nigel S. Key

Blood (2020) 135 (10): 755–765.

https://doi.org/10.1182/blood.2019001643

Published: 2020

Includes: Supplemental data

Journal Articles

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Erica B. Esrick, MD, Maureen Achebe, MD MPH, Myriam Armant, PhD, Pablo Bartolucci, MD PhD, Marioara Felicia Ciuculescu, MD, Heather Daley, Colleen Dansereau, MSN, RN, CPN, Giuseppe Di Caprio, PhD, Bronner Goncalves, MD PhD, Nicolas Hebert, Matthew M Heeney, MD, John M. Higgins, MD PhD, Leslie E. Lehmann, MD, John P Manis, MD, Olivier Negre, PhD, Sarah Nikiforow, MD PhD, Ethan Schonbrun, PhD, David K. Wood, PhD, David A. Williams, MD

Blood (2019) 134 (Supplement_2): LBA-5.

https://doi.org/10.1182/blood-2019-132745

Published: 2019

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Shyamala C. Navada, MD, Guillermo Garcia-Manero, MD, Ehab L. Atallah, MD, M. Nabeel Rajeh, MD, Jamile M. Shammo, MD, Elizabeth A. Griffiths, MD, Samer K. Khaled, MD, Shaker R. Dakhil, MD, David E. Young, MD, Rosalie Odchimar-Reissig, RN, Afoluso Ronnee Adesanya, MD, Patrick S. Zbyszewski, MBA, Richard C. Woodman, MD, Pierre Fenaux, MD PhD, Lewis R. Silverman, MD

Blood (2019) 134 (Supplement_1): 566.

https://doi.org/10.1182/blood-2019-131676

Published: 2019

Journal Articles

Prolonged Circulation of Ultra-Large Von Willebrand Factor and a Reduction in ADAMTS13 Activity Promotes Microvascular Disease Following Traumatic Injury

William E Plautz, BS, Mitchell Dyer, MD MSc, Margaret V. Ragni, MD MPH, Shannon Haldeman, Wyeth E Alexander, BS, Jason Sperry, Francis Guyette, Brian Zuckerbraun, Marian A. Rollins-Raval, MD MHP, Jay S Raval, MD, Matthew D Neal, MD

Blood (2019) 134 (Supplement_1): 444.

https://doi.org/10.1182/blood-2019-124531

Published: 2019

Journal Articles

Preclinical Evaluation for Engraftment of Gene-Edited CD34+ Cells with a Sickle Cell Disease Mutation in a Rhesus Transplantation Model

Naoya Uchida, MD, Linhong Li, PhD, Tina Nassehi, Morgan Yapundich, Jackson Gamer, Claire Drysdale, Juan J. Haro-Mora, PhD, Selami Demirci, PhD, Aylin Bonifacino, MS, Allen Krouse, Nathaniel S. Linde, Cornell Allen, MS, Suk See De Ravin, MD, PhD, Robert E. Donahue, VMD, Harry L. Malech, MD, Madhusudan Peshwa, PhD, John F. Tisdale, MD

Blood (2019) 134 (Supplement_1): 609.

https://doi.org/10.1182/blood-2019-122727

Published: 2019

Journal Articles

Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy

Ryan C. Lynch, MD, Victor A. Chow, MD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD, Mazyar Shadman, MD, Chaitra S. Ujjani, MD, Ryan D. Cassaday, MD, Brian G. Till, MD, Yolanda D. Tseng, MD, Edus H. Warren, MD PhD, Andrei R Shustov, MD, Manoj P. Menon, MD, Elizabeth Loggers, MD PhD, Jenna M. Voutsinas, MPH, Ted Gooley, PhD, Ajay K. Gopal, MD, Stephen D. Smith, MD

Blood (2019) 134 (Supplement_1): 413.

https://doi.org/10.1182/blood-2019-124857

Published: 2019

Journal Articles

Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell Disease

Soumitri Sil, PhD, Kristina Lai, MPH, Jennifer L. Lee, PhD, Jordan Gilleland-Marchak, PhD ABPP, Beth Thompson, PhD, Lindsey L Cohen, PhD, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 418.

https://doi.org/10.1182/blood-2019-130580

Published: 2019

NARROW

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing

Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage

Rapid clearance of storage-induced microerythrocytes alters transfusion recovery

How should we use convalescent plasma therapies for the management of COVID-19?

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease

Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat

HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern

HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic

Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice

PATCH trial: explanatory analyses

PATCHing platelet data to improve transfusion

Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Prolonged Circulation of Ultra-Large Von Willebrand Factor and a Reduction in ADAMTS13 Activity Promotes Microvascular Disease Following Traumatic Injury

Preclinical Evaluation for Engraftment of Gene-Edited CD34+ Cells with a Sickle Cell Disease Mutation in a Rhesus Transplantation Model

Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy

Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only